Published in Cancer Weekly, June 14th, 2005
According to a study from France, "This retrospective study sought to compare two modes of administration of RATG after renal transplantation. Before 1993, group I patients (n=93) received fixed doses of RATG (1 mg/kg per day) for 8 consecutive days."
"Thereafter, RATG was either continued at the same dose for 15 days, in cases of delayed graft function, or was infused every other day at the same dose until serum creatinine level became <150 mcmol/L," explained L. Esposito and colleagues, Centre Hospitalier de l'Universite Rangueil.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.